The integration and interpretation of pharmacogenomics – a comparative study between the United States of America and Europe: towards better health care
| Autor: | Elizabeth A. Shephard, Mark J. Bartlett |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Attitude of Health Personnel business.industry Interpretation (philosophy) Alternative medicine Public opinion United States Mini review Europe Pharmacogenetics Public Opinion Pharmacogenomics Health care Humans Medicine Pharmacology (medical) Engineering ethics Disease prevention General Pharmacology Toxicology and Pharmaceutics business Delivery of Health Care |
| Zdroj: | Drug Metabolism and Personalized Therapy. 31 |
| ISSN: | 2363-8915 2363-8907 |
| DOI: | 10.1515/dmpt-2015-0044 |
| Popis: | The study of pharmacogenomics has, by harnessing sequence information from human genomes, the potential to lead to novel approaches in drug discovery, an individualized application of drug therapy, and new insights into disease prevention. For this potential to be realized results need to be interpreted to the prescriber into a format which dictates an action. This mini review briefly describes the history, the regulatory environment, opinions towards, and implementation, integration and interpretation of pharmacogenomics in the United States of America and Europe. The article discusses also how interpretation of pharmacogenomics could move forward to better implementation in health care. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|